Search
Search Results
##search.searchResults.foundPlural##
-
WHAT ARE FUNGAL INFECTIONS?
4193PDF: 2385HTML: 27615de Pauw: 235 -
ClinicaI Reversible Myelopathy in T-Cell Lymphoblastic Lymphoma Treated with Nelarabine and Radiotherapy: Report of a Case and Review of Literature of an Increasing Complication
2378PDF: 998HTML: 1648Fig 1: 185Tab I: 213Cover Letter: 205 -
A MULTICENTER EXPERIENCE FROM LEBANON IN CHILDHOOD AND ADOLESCENT ACUTE MYELOID LEUKEMIA:HIGH RATE OF EARLY DEATH IN CHILDHOOD ACUTE PROMYELOCYTIC LEUKEMIA.
2072PDF: 1115HTML: 7696cover letter paper final AML: 214 -
CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment
1723PDF: 841HTML: 148 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3233PDF: 1010HTML: 2024 -
The EVOLVING ROLE OF HAEMATOLOGY NURSING PRACTICE: A CROSS-SECTIONAL SURVEY
1835Suppl. Files: 876HTML: 429PDF: 744 -
EFFICACY OF VENETOCLAX COMBINED WITH AZACITIDINE IN ELDERLY PATIENTS WITH RELAPSED ACUTE MYELOID LEUKEMIA
1468PDF: 768Suppl. Files: 323Html: 136 -
TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS
4324PDF: 1765HTML: 1107 -
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
2580PDF: 747HTML: 2298 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3276PDF: 1243HTML: 8106 -
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2406PDF: 937HTML: 302 -
DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA Downregulation of Scd-1 in Chronic Myeloid Leukemia
1313PDF: 1210HTML: 448 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3591PDF: 888HTML: 6711 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
7973PDF: 4145HTML: 7370 -
Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
1185PDF: 754HTML: 1348Figure 1: 186Figure 2: 189 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
3996PDF: 1054HTML: 3593Untitled: 177Cneo. Fig.1: 114Untitled: 105Untitled: 126Untitled: 133 -
Refractory Immune Thrombocytopenic Purpura and Cytomegalovirus Infection: A Call for a Change in the Current Guidelines
4255PDF: 1180HTML: 2154Figure 1: 163 -
ADVANCED HODGKIN LYMPHOMA: A NEW ERA OF THERAPY
2139PDF: 1323HTML: 3501 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2610PDF: 1611HTML: 2355Table1: 190 -
T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections
1779PDF: 703HTML: 369







